跳至主要内容
临床试验/EUCTR2020-003391-40-GB
EUCTR2020-003391-40-GB进行中(未招募)1 期

Intramuscular tranexamic acid for the treatment of symptomatic mild traumatic brain injury in older adults: a randomised, double-blind, placebo-controlled trial. - CRASH-4

ondon School of Hygiene and Tropical Medicine0 个研究点目标入组 10,000 人开始时间: 2020年9月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
10,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 70 years or older (actual or estimated)
  • History or evidence of head injury (e.g. laceration, bruise, swelling or pain in head or face)
  • Has one or more of the following symptoms:
  • ohas or had any impaired consciousness (loss of consciousness, amnesia, or confusion)
  • onausea or vomiting
  • Within 3 hours of injury (do not include if y interval cannot be estimated e.g. patient unable to confirm time of fall or patient found on floor after an unwitnessed fall and home alone)
  • Patient will be conveyed or is admitted to a participating hospital
  • Living in a nursing home, mental health institution or prison
  • TXA is clearly indicated (e.g. major bleeding) or contraindicated (e.g. suspected stroke)
  • Known to have a diagnosis of dementia
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10000

排除标准

  • Living in a nursing home, mental health institution or prison
  • TXA is clearly indicated (e.g. major bleeding) or contraindicated (e.g. suspected stroke)
  • Known to have a diagnosis of dementia

研究者

发起方
ondon School of Hygiene and Tropical Medicine

相似试验